Immunization of the preterm infant;Vaccination du prematuré

Archives de Pediatrie

Volumn 14, Issue SUPPL. 1, 2007, Pages

  Gaudelus, J ^a   Lefevre Akriche S ^a   Roumegoux, C ^a   Bolie, S ^a   Belasco, C ^a   Letamendia Richard, E ^a   Lachassinne, E ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; PALIVIZUMAB; PENTACOQ; PENTAVAC; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

APNEA; ARTICLE; BRADYCARDIA; DIPHTHERIA; DRUG INDICATION; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFANT; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; MENINGOCOCCOSIS; PERTUSSIS; PREMATURITY;

AGE FACTORS; APNEA; BCG VACCINE; BRADYCARDIA; GESTATIONAL AGE; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFLUENZA VACCINES; MEASLES-MUMPS-RUBELLA VACCINE; MONITORING, PHYSIOLOGIC; PERTUSSIS VACCINE; PNEUMOCOCCAL VACCINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; VACCINATION; VACCINES, COMBINED;

EID: 35248852432     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(07)80007-8     Document Type: Article

References (49)

1. Langkamp D. Davis JP. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr 128 (1996) 654-659
2. Wortis N., Strebel P., Wharton M., et al. Pertussis death: report of 23 cases in the United States, 1992 and 1993. Pediatrics 97 (1996) 607-612
3. Sarlangue J., and Brissaud O. Le risque infectieux chez l'ancien « grand prématuré « et sa prévention. Arch Pediatr 9 4 (2002) 435S-437S
4. Gaudelus J. Vaccination anti-virus respiratoire syncytial. Virologie 7 (2003) S170-S176
5. Floret D., Salle B., and Claris O. Faut-il vacciner les prématurés ?. Arch Pediatr 6 (1999) 607-609
6. Siegrist C. Quand et comment vacciner les anciens prématurés ?. Médecine et Hygiène 58 (2000) 350-353
7. Siegrist C. Vaccinations et réponses immunitaires du nourrisson. Medecine et Enfance 20 (1998) 581-584
8. Gaudelus J., Cohen R., and Siegrist C. Vaccinologie néonatale : bases théoriques. In: Flammarion Medecine Sciences éditeur (Ed). Journées Parisiennes de Pédiatrie (2004) 255-260
9. Reinert P., and Gaudelus J. Progrés immunologiques apportés par les vaccins conjugués. Med Therap Pediatrie 2 (2002) 31-35
10. Barrios C., Brawand P., Berney M., et al. Néonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a TH2-biased pattern which persists after adult boosting. Eur J Immunol 26 (1996) 1489-1496
11. Dawodu A. Tuberculin conversion following BCG vaccination in preterm infants. Acta paediatr Scand 74 (1985) 504-507
12. Thayyil-Sudhan S., Kumar A., Singh M., et al. Safety and effectiveness of BCG vaccination in preterm babies. Arch Dis Child Fetal Neonatal Ed 81 (1999) F64-F66
13. Sebaghatian M., Hashem F., and Hossain M. Bacille Calmette Guerin vaccination in preterm infants. Int J Tuberc lung Dis 2 (1998) 679-682
14. Bernbaum J., Daft A., Anolick R., et al. Response of preterm infants to diphteria-tetanus-pertussis immunizations. J Pediatr 107 (1985) 184-188
15. Linder N., Yaron M., Handsher R., et al. Early immunization with inactivated polio-virus vaccine in premature infants. J Pediatr 127 (1995) 128-130
16. Conway S., James J., Balfour A., et al. Immunization of the preterm baby. J Infect 27 (1993) 143-150
17. Pullan C., and Hull D. Routine immunization of preterm infants. Arch Dis Child 64 (1989) 1438-1441
18. Adenyi-Jones S., Faden H., Ferdon M., et al. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. J Pediatr 120 (1992) 686-689
19. D'Angio C., Maniscalo M., and Pichichero M. Immunologic response of extremely premature infants to tetanus, haemophilus influenzae and polio immunizations. Pediatrics 96 (1995) 18-22
20. Pistilli A., Regoli D., Podda A., et al. Safety and immunogenicity of a recombinant pertussis vaccine in premature and term infants. Riv Ital Pediat 21 (1995) 221-228
21. Schloessler R., Ficher D., Otto W., et al. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 103 (1999) 1021
22. Munoz A., Salvador A., Brodsky N., et al. Antibody response of low birth weight infants to Haemophilus influenzae type b Polyribosylribitol phosphate-outer Membrane Protein conjugate vaccine. Pediatrics 96 (1995) 216-219
23. Kristensen K., Gyhrs A., Lausen B., et al. Antibody response to Haemohilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J 15 (1996) 525-529
24. Robinson M., Campbell P., Powell, et al. Antibody response to accelerated Hib immunization in preterM infants receiving dexamethasone for chronic ling disease. Arch Dis Child Fetal Neonatal Ed 80 (1999) F69-F71
25. Lauy L., Tam A., Ng K., et al. Response of preterm infants to hepatitis B vaccine. J Pediatr 121 (1992) 962S
26. Losonsky G., Wasserman S., and Stefens I. Hepatitis B. Vaccination of premature infants. A reassessment of current recommendation for delayed immunization. Pediatrics 103 (1999) 487
27. Patel S., Butler J., Feldman S., et al. Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants. Pediatr 131 (1997) 641-643
28. Kim S., Chung E., Hodinka R., et al. Immunogenicity of hepatitis B vaccine in preterm infants. Pediatrics 99 (1997) 534-536
29. Blondheim O., Bader D., Abend M., et al. Immunogenicity of hepatitis B vaccine in preterm infants. Arch Dis Child Fetal Ed 79 (1998) 206-208
30. Belloni C., Chirico G., Pistorio A., et al. Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr 87 (1998) 336-338
31. Kirmani K., Lofthus G., Pichichero M., et al. Seven year follow up of vaccine response in extremely premature infants. Pediatrics 109 (2002) 498-504
32. Kesler K., Nasenbeny J., Wainwight R., et al. Immune responses of prematurely born infants to hepatitis B vaccination: results through three years of age. Pediatr Infect Dis J 17 (1998) 116-119
33. Saara T., and the committee on infectious diseases. American Academy of Pediatrics. Immunization of preterm and low birth weight infants. Pediatrics 112 (2003) 193-198
34. Black S., Shinefield H., Fireman B., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanent Vaccine Study Center Group. Pediatr Infect Dis J 19 (2000) 187-195
35. Shinefield H., Black S., Ray P., et al. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis j 21 (2002) 182-186
36. Groothuis J., Levin M., Leh M., et al. Immune response to split- product influenza vaccine in preterm and full term young children. Vaccine 10 (1992) 221-225
37. Slack H., Schapira D., Thwaites R., et al. Immune response of premature infants to meningococcal serogroup C and combined diphteria-tetanus toxoids, acellular pertussis, Haemophilus influenzae type b conjugate vaccine. J Infect Dis 184 (2001) 1617-1620
38. Collins C., Ruggeberg J., Balfour G., et al. Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants. Pediatr Infect Dis J 24 (2005) 966-968
39. Robinson M., Heal C., Gardener E., et al. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease. Pediatrics 113 (2004) 733-737
40. Robinson M., Campbell F., Powell P., et al. Antibody response to accelerated Hib immunization in preterm infants receiving immunisation for chronic lung disease. Arch Dis Child Fetal Neonatal Ed 80 (1999) F69-F71
41. Clarke P., Powell P., Goldblatt D., et al. Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed 88 (2003) F58-F61
42. Saliou P., Ajjan N., and Guerin N. Efficacité et tolérance des vaccinations chez les prématurés. Arch Pediatr 9 (2002) 629-637
43. Botham S., and Isaacs D. Incidence of apnea and bradycardia in preterm infants following triple antigen immunization. J Pediatr Child Health 30 (1994) 533-535
44. Botham S., Issacs D., and Henderson D. Incidence of apnea and bradycardia in preterm infants following DTP and Hib immunization: a prospective study. J Pediatr Child Health 33 (1997) 418-421
45. Sanchez P., Laptook A., Fisher L., et al. Apnea after immunization of preterm infants. J Pediatr 130 (1997) 746-751
46. Slack M., and Schapira D. Severe apneas following immunisation in premature infants. Arch Dis Child Fetal Neonatal Ed. 81 (1999) 67-68
47. Sen S., Cloete Y., Hassan K., et al. Adverse events following vaccination in premature infants. Acta Paediatr 90 (2001) 916-920
48. Lefevre-Akriche S., Farnoux C., Le Huidoux P., et al. Tolérance de la vaccination pentavalente contre diphtérie, tétanos, coqueluche, poliomyé1ite et Haemophilus influenzae B chez le prématuré. In: Flammarion Medecine Sciences éditeur (Ed). Journées Parisiennes de Pédiatrie (2003) 133-139
49. Pfister R., Aeschbach V., Niksic-Stuber V., et al. Safety of DTaP- based combined immunization in very low birth weight premature infants : frequent but mostly benign cardiorespiratory events. J Pediatr 14 (2004) 58-66